There are 2867 resources available
752P - Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer
Presenter: Anja Seckinger
Session: Poster session 13
753P - Targeting solid tumors with IMA402, a next-generation bispecific T cell engaging receptor against PRAME
Presenter: Sarah Missel
Session: Poster session 13
754P - A phase I/IIa dose escalation study of AFM24 in patients with epidermal growth factor receptor-expressing (EGFR) solid tumors: Results from phase I
Presenter: Anthony El-Khoueiry
Session: Poster session 13
755P - B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cells
Presenter: Jeffrey Miller
Session: Poster session 13
756P - Glypican-3 (GPC3) and NKp46 directed FLEX-NK engager antibody (CYT-303) recruits natural killer (NK) cells to tumors in a preclinical hepatocellular carcinoma (HCC) mouse model
Presenter: Antonio Arulanandam
Session: Poster session 13
758P - A comprehensive analysis of tumor-infiltrating immune cells in HPV-associated cancers
Presenter: Hong Yang
Session: Poster session 14
759P - Preconditioning with irradiation enhances efficacy of B7-H3-CAR-T in treating solid tumor models
Presenter: Tian Wang
Session: Poster session 14
760P - Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: A randomized study
Presenter: Lei Huang
Session: Poster session 14
761P - Tumor infiltrating lymphocytes expressing membrane-bound IL-2 and IL-12 exhibit enhanced proliferation, function, and persistence without requiring exogenous IL-2 support
Presenter: Rebecca J. Silver
Session: Poster session 14